J&J expands it long-acting injectables partnership with Midatech
Midatech Pharma (Nasdaq:MTP) announced today that it extended its R&D collaboration with Johnson & Johnson's Janssen Pharmaceuticals.
Stay updated with breaking news from Midatech Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Midatech Pharma (Nasdaq:MTP) announced today that it extended its R&D collaboration with Johnson & Johnson's Janssen Pharmaceuticals.
ABINGDON, UK / ACCESSWIRE / March 8, 2022 / Midatech Pharma PLC (AIM:MTPH; NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicine, is pleased
LONDON--(BUSINESS WIRE)--Feb 10, 2022--
Nick Robbins-Cherry, ex-Midatech, joins as CFO George O'Rourke, joins as VP GM Ixaka France, from Novartis Gene Therapy Ixaka Ltd, an integrated cell and gene therapy company focused on the
/PRNewswire/ -- The "Long-Acting Injectable Drugs" report has been added to ResearchAndMarkets.com's offering. Chronic conditions require drug administration...